The Superbug Fight Needs a Better Business Model
The current pipeline for new antibiotics is “on the verge of collapse” within the next four to eight years—and a key reason is that antibiotic makers can’t stay in business.
Preventive medicine synthesizes clinical and population-based approaches to disease prevention and health promotion
Explore the latest public health research and insights about medicine.
The current pipeline for new antibiotics is “on the verge of collapse” within the next four to eight years—and a key reason is that antibiotic makers can’t stay in business.
Looking for prominent public health experts in the field of medicine? They’re here at the Bloomberg School of Public Health.
Albert Wu, MD, MPH, studies the impact of safety problems on patients and health care workers.
Gerard Anderson, PhD, works with policymakers to control health care spending.
Katherine Clegg Smith, PhD, MA, is a sociologist who examines health experiences and health communication, with a research focus on cancer and chronic disease.